Metformin Alters Human Host Responses to Mycobacterium tuberculosis in Healthy Subjects-Reference-Cited by-同舟云学术

Metformin Alters Human Host Responses to Mycobacterium tuberculosis in Healthy Subjects

Published:2019-02-12 Issue:1 Volume:220 Page:139-150
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Lachmandas Ekta¹²,Eckold Clare³,Böhme Julia⁴,Koeken Valerie A C M¹²,Marzuki Mardiana Binte⁴,Blok Bastiaan¹²,Arts Rob J W¹²,Chen Jinmiao⁴,Teng Karen W W⁴,Ratter Jacqueline¹²⁵,Smolders Elise J¹²,Van den Heuvel Corina¹²,Stienstra Rinke¹²⁵,Dockrell Hazel M³,Newell Evan⁴,Netea Mihai G¹²⁶,Singhal Amit⁴⁷,Cliff Jacqueline M³,Van Crevel Reinout¹²

Affiliation:

1. Department of Internal Medicine, Nijmegen

2. Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen

3. Department of Immunology and Infection, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, United Kingdom

4. Singapore Immunology Network, Agency for Science, Technology, and Research

5. Nutrition, Metabolism and Genomics Group, Division of Human Nutrition, Wageningen University, Wageningen, the Netherlands

6. Human Genomics Laboratory, Craiova University of Medicine and Pharmacy, Romania

7. Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore

Funder

Netherlands Organization for Scientific Research

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiz064/28543682/jiz064.pdf

Reference37 articles.

1. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies;Jeon;PLoS Med,2008

2. The impact of diabetes on tuberculosis treatment outcomes: a systematic review;Baker;BMC Med,2011

3. Rewiring cellular metabolism via the AKT/mTOR pathway contributes to host defence against Mycobacterium tuberculosis in human and murine cells;Lachmandas;Eur J Immunol,2016

4. Metformin as adjunct antituberculosis therapy;Singhal;Sci Transl Med,2014

5. Latent tuberculosis in patients with diabetes mellitus: prevalence, progression and public health implications;Leow;Exp Clin Endocrinol Diabetes,2014

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tuberculosis and diabetes mellitus: The complexity of the comorbid interactions;International Journal of Infectious Diseases;2024-09

2. Host-directed therapy with amiodarone in preclinical models restricts mycobacterial infection and enhances autophagy;Microbiology Spectrum;2024-08-06

3. Mycobacterium tuberculosis strain with deletions in menT3 and menT4 is attenuated and confers protection in mice and guinea pigs;Nature Communications;2024-06-27

4. Metformin as adjunctive therapy in combination with multidrug treatment for multibacillary leprosy: A protocol for a randomized double-blind, controlled Phase 2 trial in Indonesia (MetLep Trial);Wellcome Open Research;2024-05-09

5. Metformin has immunomodulatory effects which support its potential use as adjunctive therapy in tuberculosis;Indian Journal of Tuberculosis;2024-01